GPR52 agonists attenuate ropinirole-induced preference for uncertain outcomes.
Sign Up to like & getrecommendations! Published in 2020 at "Behavioral neuroscience"
DOI: 10.1037/bne0000391
Abstract: Dopamine D2/3 receptor agonists are less likely to trigger dyskinesias than L-dopa while still offering relief from the motor symptoms of Parkinson's disease (PD). However, these drugs can cause serious impulse control problems and gambling… read more here.
Keywords: preference uncertain; ropinirole; gpr52 agonists; uncertain outcomes ... See more keywords